SNT Appendix 4C - quarterly 30/04/21 PRICE SENSITIVE download Created with Sketch. 179.97KB Share SNT Appendix 2A - Exercise of Employee Options 22/04/21 download Created with Sketch. 193.48KB Share SNT Section 708A(5)(e) Notice 21/04/21 download Created with Sketch. 140.61KB Share SNT Becoming a substantial holder 20/04/21 download Created with Sketch. 183.5KB Share SNT Appendix 2A 20/04/21 download Created with Sketch. 192.06KB Share SNT Sale of Russian Distribution Rights 14/04/21 PRICE SENSITIVE download Created with Sketch. 144.32KB Share SNT Investor Presentation Capital Raising and Growth Outlook 14/04/21 PRICE SENSITIVE download Created with Sketch. 2.45MB Share SNT Proposed issue of Securities - PXS 14/04/21 download Created with Sketch. 24.78KB Share SNT Placement 14/04/21 PRICE SENSITIVE download Created with Sketch. 146.13KB Share SNT Trading Halt 13/04/21 PRICE SENSITIVE download Created with Sketch. 218.32KB Share SNT Investor Presentation 07/04/21 download Created with Sketch. 3.32MB Share SNT Appendix 2A - Exercise of Employee Options 07/04/21 download Created with Sketch. 193.49KB Share SNT Clinical Trial of Treatment to Prevent Wound and Burns Scars 31/03/21 download Created with Sketch. 128.74KB Share SNT US Commercial Launch of Bronchitol 19/03/21 download Created with Sketch. 99.5KB Share SNT First Patient Enrolled - Clinical Trial for Cancer Treatment 22/02/21 PRICE SENSITIVE download Created with Sketch. 132.47KB Share SNT Appendix 2A - Exercise of Employee Options 15/02/21 download Created with Sketch. 193.44KB Share SNT Half Yearly Report and Accounts 10/02/21 PRICE SENSITIVE download Created with Sketch. 430.36KB Share SNT Pharmaxis Exports CF Drug to US - US$3 Million Milestone 09/02/21 PRICE SENSITIVE download Created with Sketch. 101.56KB Share SNT Appendix 4C - quarterly 29/01/21 PRICE SENSITIVE download Created with Sketch. 180.59KB Share SNT Quarterly Activity Report - December 2020 29/01/21 PRICE SENSITIVE download Created with Sketch. 488.55KB Share SNT Pharmaxis Receives US$7m milestone from Chiesi 29/12/20 PRICE SENSITIVE download Created with Sketch. 96.51KB Share SNT Appendix 2A - exercise of employee options 17/12/20 download Created with Sketch. 193.48KB Share SNT Pharmaxis to Present at Proactive CEO Investor Session 10/11/20 download Created with Sketch. 101.35KB Share SNT Change in substantial holding 06/11/20 download Created with Sketch. 126.59KB Share SNT Change of Director's Interest Notice 04/11/20 download Created with Sketch. 140.69KB Share SNT Appendix 3G - Employee Options 04/11/20 download Created with Sketch. 239.76KB Share SNT Results of Meeting 04/11/20 download Created with Sketch. 185.75KB Share SNT CEO Presentation to AGM 04/11/20 download Created with Sketch. 1.71MB Share SNT Chairman's Address to Shareholders 04/11/20 download Created with Sketch. 148.49KB Share SNT Ceasing to be a substantial holder from Arix Bioscience 03/11/20 download Created with Sketch. 234.45KB Share SNT MEDIA RELEASE BRONCHITOL FDA and MF Trial 02/11/20 download Created with Sketch. 125.15KB Share SNT Investor Presentation 02/11/20 download Created with Sketch. 3.12MB Share SNT Investor Teleconference 02/11/20 download Created with Sketch. 111.81KB Share SNT Pharmaxis Prioritises Clinical Program on Myelofibrosis 02/11/20 PRICE SENSITIVE download Created with Sketch. 136.14KB Share SNT FDA Approves Bronchitol for US Market 02/11/20 PRICE SENSITIVE download Created with Sketch. 133.59KB Share SNT Appendix 4C - quarterly 30/10/20 PRICE SENSITIVE download Created with Sketch. 181.37KB Share SNT September Quarter 2020 Activity Report 30/10/20 PRICE SENSITIVE download Created with Sketch. 364.14KB Share SNT Change in substantial holding from Arix Bioscience 23/10/20 download Created with Sketch. 160.26KB Share SNT Change in substantial holding 20/10/20 download Created with Sketch. 193.29KB Share SNT Pharmaxis Receives $5m R&D Tax Incentive 14/10/20 download Created with Sketch. 100.74KB Share SNT Corporate Governance Statement 02/10/20 download Created with Sketch. 194.81KB Share SNT Appendix 4G 02/10/20 download Created with Sketch. 181.15KB Share SNT Notice of Annual General Meeting/Proxy Form 02/10/20 download Created with Sketch. 1.43MB Share SNT Annual Report to shareholders 02/10/20 download Created with Sketch. 906.68KB Share SNT Appendix 2A - exercise of employee options 01/10/20 download Created with Sketch. 193.48KB Share SNT Appendix 2A - Exercise of Employee Options 24/09/20 download Created with Sketch. 193.5KB Share SNT Appendix 2A - Exercise of Employee Options 18/09/20 download Created with Sketch. 194.58KB Share SNT Date of Virtual AGM and Closing Date for Director Nomination 16/09/20 download Created with Sketch. 708.37KB Share SNT Boehringer Ingelheim discontinues development of BI 1467335 07/09/20 PRICE SENSITIVE download Created with Sketch. 684.06KB Share SNT Pharmaxis Awarded $1M Australian Government Grant 03/09/20 PRICE SENSITIVE download Created with Sketch. 123.9KB Share SNT Appendix 2A - Employee Option Exercise 25/08/20 download Created with Sketch. 194.52KB Share SNT Appendix 2A - 2020 Employee Share Plan Grant 24/08/20 download Created with Sketch. 197.88KB Share SNT Ceasing to be a substantial holder from AEF 24/08/20 download Created with Sketch. 251.39KB Share SNT FDA Gives Green Light to Start Myelofibrosis Phase 2 Study 19/08/20 PRICE SENSITIVE download Created with Sketch. 91.4KB Share SNT Change in substantial holding from AEF 19/08/20 download Created with Sketch. 108.98KB Share SNT Appendix 2A - Exercise of employee options 14/08/20 download Created with Sketch. 195.09KB Share SNT Final Director's Interest Notice 14/08/20 download Created with Sketch. 111.29KB Share SNT Resignation of Non Executive Director Edward Rayner 14/08/20 download Created with Sketch. 99.44KB Share SNT Proposed Issue of Securities to Chief Executive Officer 13/08/20 download Created with Sketch. 159.76KB Share SNT Appendix 3G - 2020 Grant of Performance Rights 13/08/20 download Created with Sketch. 239.82KB Share SNT Change of Director's Interest Notice - G Phillips 13/08/20 download Created with Sketch. 143.82KB Share SNT Lapse of 2019 Performance Rights and Expiry of Options 13/08/20 download Created with Sketch. 154.09KB Share SNT Preliminary Final Report 13/08/20 PRICE SENSITIVE download Created with Sketch. 934.75KB Share SNT US$7 million Bronchitol Launch Milestone Brought Forward 05/08/20 PRICE SENSITIVE download Created with Sketch. 101.07KB Share SNT Fourth Quarter Activity Report 31/07/20 PRICE SENSITIVE download Created with Sketch. 385.4KB Share SNT Appendix 4C - quarterly 31/07/20 PRICE SENSITIVE download Created with Sketch. 173.02KB Share SNT Pharmaxis Submits IND Application for Myelofibrosis 23/07/20 download Created with Sketch. 90.96KB Share SNT FDA Grants Orphan Drug Status for PXS Anti Fibrotic Drug 14/07/20 download Created with Sketch. 144.14KB Share SNT PHARMAXIS TO PRESENT AT MONSOON COMMUNICATIONS WEBINAR 02/06/20 download Created with Sketch. 96.1KB Share SNT Appendix 2A - Exercise of Employee Options Number 2 18/05/20 download Created with Sketch. 214.52KB Share SNT Appendix 2A - Exercise of Employee Options 18/05/20 download Created with Sketch. 214.56KB Share SNT Bronchitol NDA Resubmission - FDA Decision Date 1 November 13/05/20 download Created with Sketch. 511.37KB Share SNT Chiesi Files Resubmission for Bronchitol with FDA 05/05/20 download Created with Sketch. 106.46KB Share SNT Initial Director's Interest Notice 04/05/20 download Created with Sketch. 207.87KB Share SNT Pharmaxis Appoints Dr Neil Graham as Director 04/05/20 download Created with Sketch. 102.66KB Share SNT Investor Presentation 01/05/20 download Created with Sketch. 987.78KB Share SNT Pharmaxis CEO to Present at Virtual Health Conference 30/04/20 download Created with Sketch. 103.05KB Share SNT Appendix 4C - quarterly 30/04/20 PRICE SENSITIVE download Created with Sketch. 88.08KB Share SNT Pharmaxis Quarterly Shareholder Update - March 2020 30/04/20 PRICE SENSITIVE download Created with Sketch. 392.68KB Share SNT PXS Cancer Drug Ready to Commence Phase 2 Studies Q4 2020 28/04/20 PRICE SENSITIVE download Created with Sketch. 145.17KB Share SNT Appendix 2A - Exercise of Employee Options 06/04/20 download Created with Sketch. 113.17KB Share SNT Appendix 2A - Exercise of Employee Options 12/03/20 download Created with Sketch. 99.37KB Share SNT Half Yearly Report and Accounts 13/02/20 PRICE SENSITIVE download Created with Sketch. 251.24KB Share SNT Appendix 2A 13/02/20 download Created with Sketch. 99.51KB Share SNT Appendix 3G - Exercise of Employee Options 12/02/20 download Created with Sketch. 78.53KB Share SNT Appendix 4C - quarterly 31/01/20 PRICE SENSITIVE download Created with Sketch. 121.39KB Share SNT Quarterly Shareholder Update - December 2019 31/01/20 PRICE SENSITIVE download Created with Sketch. 372.47KB Share SNT Ceasing to be a substantial holder 20/12/19 download Created with Sketch. 162.14KB Share SNT Pharmaxis Business Plan Update 18/12/19 PRICE SENSITIVE download Created with Sketch. 112.13KB Share SNT Boehringer discontinues development of BI 1467335 for NASH 18/12/19 PRICE SENSITIVE download Created with Sketch. 120.18KB Share SNT Investor Conference Call 17/12/19 download Created with Sketch. 108.98KB Share SNT Trading Halt 16/12/19 PRICE SENSITIVE download Created with Sketch. 101.39KB Share SNT Investor Presentation 25/11/19 download Created with Sketch. 963.76KB Share SNT Change of Director's Interest Notice 21/11/19 download Created with Sketch. 70.45KB Share SNT Appendix 3B - Issue of Employee Options 21/11/19 download Created with Sketch. 129.97KB Share SNT Results of Meeting 21/11/19 download Created with Sketch. 227.66KB Share SNT CEO Presentation to 2019 AGM 21/11/19 download Created with Sketch. 959.76KB Share SNT Chairman's Address to Shareholders 21/11/19 download Created with Sketch. 95.4KB Share SNT Appendix 3B - Grant of Employee Options 06/11/19 download Created with Sketch. 129.56KB Share SNT Appendix 4C - quarterly 31/10/19 PRICE SENSITIVE download Created with Sketch. 121.37KB Share